Found 231 matching trials
Study of Osimertinib + SRS vs Osimertinib Alone for Brain Metastases in EGFR Positive Patients With NSCLC PHASE2 This open-label, multicenter, randomized phase II study will evaluate the u...
Show More Status
Active Not Recruiting
Location
BC Cancer, Vancouver Centre
Learn More & Join Trial
Stereotactic Body Radiation Therapy for Inoperable Locally-advanced Non-small Cell Lung Cancer PHASE1 The purpose of this study is to determine if the use of exploratory immunol...
Show More Location
Memorial Sloan Kettering Cancer Center at Basking Ridge
Learn More & Join Trial
MRI Study of Changes in Blood-Brain/Tumor-Barrier Permeability in Patients With Brain Metastases During and After Radiotherapy N/A This study aims to assess changes in vascular permeability in the brain tum...
Show More Location
University of Michigan Hospital
Learn More & Join Trial
Stereotactic Radiosurgery in Treating Patients With Spinal Metastases PHASE1 RATIONALE: Stereotactic radiosurgery can send x-rays directly to the tumor ...
Show More Location
Boston University Cancer Research Center
Learn More & Join Trial
Hypofractionated Versus Single Fraction Stereotactic Adjuvant Radiotherapy to the Resection Cavity of Brain Metastases NA This prospective, randomized, controlled, monocentric clinical phase III st...
Show More Location
Dept. Radiation Oncology
Learn More & Join Trial
Stereotactic Radiotherapy for Metastatic Kidney Cancer Being Treated With Sunitinib PHASE2 Stereotactic radiotherapy (SRT) is a newer type of focused radiation therap...
Show More Location
Tom Baker Cancer Centre
Learn More & Join Trial
A Study of Stereotactic Body Radiation Therapy (SBRT) Without Androgen Deprivation Therapy (ADT) in People With Unfavorable Intermediate-Risk Prostate Cancer PHASE2 The researchers are doing this study to find out if stereotactic body radia...
Show More Status
Active Not Recruiting
Location
Memorial Sloan Kettering Basking Ridge (All Protocol Activities)
Learn More & Join Trial
Erlotinib and SBRT in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer PHASE2 RATIONALE: Erlotinib may stop the growth of tumor cells by blocking some of...
Show More Location
University of Colorado Cancer Center at UC Health Sciences Center
Learn More & Join Trial
Early Salvage Stereotactic Radiotherapy for Biochemical Failure After RP PHASE2 After radical prostatectomy, 30-60% of patients will develop recurrent dise...
Show More Location
Regina Elena National Cancer Institute
Learn More & Join Trial
Image-Guided Stereotactic Radiosurgery (SRS) Boost for HPV-Oropharyngeal Cancer NA This is a Phase I study looking to evaluate the safety of dose escalated st...
Show More Location
Northwell Health- Center for Advanced Medicine
Learn More & Join Trial